Anti-CEA CAR T Cells clinical trials
How each study uses Anti-CEA CAR T Cells is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Anti-CEA CAR T Cells studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 6
Roger Williams Medical Center (4) · Chongqing Precision Biotech Co., Ltd (3) · Sorrento Therapeutics, Inc. (2) · Weijia Fang, MD (1) · Changhai Hospital (1)
Often tested with
Tested in the same studies.
GNP Regimen (1) · Irinotecan sucrosofate (1) · Irinotecan (1) · Capecitabine (1)
Studies
Open first, then newest update. How each study uses Anti-CEA CAR T Cells is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid TumorsRecruitingPhase 1Chongqing Precision Biotech Co., LtdNCT06010862Written as CEA CAR-T cellsHow we know
- Anti-CEA CAR-T Cells to Treat Colorectal Liver MetastasesRecruitingPhase 1Changhai HospitalNCT05240950Written as Anti-CEA CAR-T CellsHow we know
- A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid TumorsCompletedPhase 1Weijia Fang, MDNCT05396300Written as CEA CAR-T cellsHow we know
- Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ CancerWithdrawnPhase 1/2Chongqing Precision Biotech Co., LtdNCT04348643Written as CEA CAR-T cellsHow we know
- Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid TumorsCompletedPhase 1Chongqing Precision Biotech Co., LtdNCT05415475Written as CEA CAR-T cellsHow we know
- CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)WithdrawnPhase 1Sorrento Therapeutics, Inc.NCT03682744Written as anti-CEA CAR-T cellsHow we know
- Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver MetastasesWithdrawnPhase 2/3Sorrento Therapeutics, Inc.NCT04037241Written as Anti-CEA CAR-T cellsHow we know
- CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas CancerCompletedPhase 1Roger Williams Medical CenterNCT02850536Written as anti-CEA CAR-T cellsHow we know
- CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver MetastasesCompletedPhase 1Roger Williams Medical CenterNCT02416466Written as anti-CEA CAR-T cellsHow we know
- Trial of Second Generation Designer T Cells in Colorectal CarcinomaTerminatedPhase 1Roger Williams Medical CenterNCT00673322Written as Gene Modified T CellsHow we know
- CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T CellsCompletedPhase 1Roger Williams Medical CenterNCT01373047Written as anti-CEA 2nd generation designer T cellsHow we know